Quality Assured
Supplied across India with dependable dispatch.
RABECLAIR DSR
Rabeprazole Sodium & Domperidone Sustained Release Capsules
RABECLAIR DSR combines Rabeprazole for rapid, powerful 24-hour gastric acid suppression with Domperidone SR for normalized upper GI motility, eliminating both acid reflux and associated nausea.
Product Specifications
| Composition | Each hard gelatin capsule contains: Rabeprazole Sodium IP (Enteric Coated) 20 mg + Domperidone IP (Sustained Release) 30 mg |
| Pack Size | 10 x 10 Capsules (Alu-Alu) |
| Dosage Form | Capsule |
| Storage | Store in a cool, dry place below 30°C. Protect from light. |
Therapeutic Indications
Key Formulation USPs
- Fastest onset of acid inhibition among PPIs (within 1 hour)
- Dual enteric-coated pellets + sustained release prokinetic beads
- Prevents nocturnal acid breakthrough and daytime reflux flares
- Safe and well-tolerated long-term gastroprotection
- Premium moisture-impermeable Alu-Alu strip packaging
Frequently Asked Questions About RABECLAIR DSR
Essential product details, active salt composition, dosage specifications, and PCD franchise distribution queries answered.
RABECLAIR DSR is a pharmaceutical capsule containing Rabeprazole Sodium & Domperidone Sustained Release Capsules. It is manufactured by Medizons International Pvt. Ltd. and primarily indicated for Gastroesophageal Reflux Disease (GERD) and Acid Reflux, Peptic, Gastric, and Duodenal Ulcers, Heartburn, epigastric pain, and acid regurgitation, NSAID-induced dyspepsia and gastropathy, Nausea and vomiting associated with hyperacidity.